Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Abiomed, Inc.
Cardiovascular device firm reports that net losses narrow substantially
September 10th, 2003
Abiomed, Inc., (ABMD) released financial results for the first quarter of fiscal year 2004 ended June 30, 2003, and commented on significant highlights of the quarter and recent weeks. "During the fiscal first quarter we presented our view of the United States circulatory support patient population, and reaffirmed our intention ultimately to compete in every segment of the circulatory assist and replacement business. All our efforts, both in research and development and in the realignment of the company's operations late last calendar year, are designed to achieve this goal," said chairman and CEO David M. Lederman. "We are satisfied that Abiomed is making progress...
Source: Biotech Week (2003-09-10)
|
